Monopar Therapeutics Inc (MNPR) is up Wednesday morning, with the stock climbing 5.79% in pre-market trading to 1.28. MNPR's short-term technical score of 65 indicates that the stock has traded more bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 85 out of 146 industries, Monopar Therapeutics Inc ranks higher than 74% of stocks. Monopar Therapeutics Inc has risen 236.11% over the past month, closing at $0.34 on January 31. During this period of time, the stock fell as low as $0.31 and as high as $1.73. MNPR has an average analyst recommendation of Strong Buy. The company has an average price target of $8.50.
MNPR has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on MNPR!